Table 3.
Outcome | MR ± IR opioids | IR opioids only | p value |
---|---|---|---|
n = 347 | n = 347 | ||
Total all ORADEs | 71 (20.5%) | 44 (12.7%) | 0.008 |
Total gastro‐intestinal ORADEs | 37 (10.7%) | 15 (4.3%) | 0.002 |
Constipation | 20 (5.8%) | 6 (1.7%) | 0.008 |
Nausea and vomiting | 16 (4.6%) | 8 (2.3%) | 0.144 |
Heartburn | 1 (0.3%) | 1 (0.3%) | 1.000 |
Diarrhoea | 0 | 0 | N/A |
Abdominal pain | 1 (0.3%) | 0 | 1.000 |
Other gastro‐intestinal ORADEs | 0 | 1 (0.3%) | 1.000 |
Total central nervous system ORADEs | 13 (3.7%) | 8 (2.3%) | 0.376 |
Somnolence | 3 (0.9%) | 0 | 0.249 |
Delirium a | 7 (2%) | 6 (1.7%) | 1.000 |
Dizziness | 2 (0.6%) | 2 (0.6%) | 1.000 |
Headache | 1 (0.3%) | 1 (0.3%) | 1.000 |
Hallucinations | 0 | 0 | N/A |
Sleep disturbance | 1 (0.3%) | 0 | 1.000 |
Other central nervous system ORADEs | 0 | 0 | N/A |
Respiratory depression | 9 (2.6%) | 8 (2.3%) | 1.000 |
Urinary retention | 14 (4%) | 15 (4.3%) | 1.000 |
Other ORADEs (total) | 7 (2.0%) | 3 (0.9%) | 0.340 |
Pruritis | 1 (0.3%) | 2 (0.6%) | 1.000 |
Dry mouth | 1 (0.3%) | 0 | 1.000 |
Opioid toxicity | 0 | 0 | N/A |
In‐hospital fall | 6 (1.7%) | 0 | 0.031 |
Muscle spasm | 0 | 1 (0.3%) | 1.000 |
N/A, not applicable.
Not due to infective sources or substance withdrawal.